Killer Activated and Killer Inhibitor Receptors

Killer Activated Receptors (KARs) and Killer Inhibitor Receptors (KIRs) are important molecules located on the surface of certain types of cells in the immune system. KARs are activated when they interact with molecules from their environment and cause the cells to become “killer” cells, which are able to recognize and destroy foreign or damaged cells. KIRs, on the other hand, act as inhibitors of KAR activation by suppressing the “killer” activity. Both KARs and KIRs play a key role in the immune system, helping it to respond to foreign invaders and damaged cells. They are also important for maintaining healthy tissue and preventing autoimmune diseases, in which the body’s own cells are targeted by its immune system. The research into KARs and KIRs is ongoing, and their significance and potential uses continue to be explored.

← International Journal of Cell

Related Articles

8 article(s) found

Etodolac, A Preferential COX-2 Inhibitor, does not Inhibit Platelet Aggregation in a Randomized Placebo-Controlled Trial

Full-text HTML Download PDF Download XML

Ciliary Neurotrophic Factor Activated Signaling Pathways in Retinal Müller Cells

Full-text HTML Download PDF Download XML

Recurrent branch retinal arterial occlusions associated with plasminogen activator inhibitor-1 mutation

Full-text HTML Download PDF Download XML

Nucleoside and Nucleotide Reverse Transcriptase Inhibitors Induce Aging by Inhibiting Telomerase Function

Full-text HTML Download PDF Download XML

Cross-Reactivity between COX-2 Inhibitors in Patients with Cross-Reactive Hypersensitivity to NSAIDs

Full-text HTML Download PDF Download XML

Tridax Procumbens Inhibitory Properties of Alpha Amylase

Full-text HTML Download PDF Download XML

Dogonyaro-Leaf-Extract as Inhibitor for Aluminum Corrosion in Acid

Full-text HTML Download PDF Download XML

Natural Polyphenols as Inhibitors for the Binding of Covid-19 S-RBD with ACE-2

Full-text HTML Download PDF Download XML